Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 489


Cost-effectiveness of a disease management programme for secondary prevention of coronary heart disease and heart failure in primary care.

Turner DA, Paul S, Stone MA, Juarez-Garcia A, Squire I, Khunti K.

Heart. 2008 Dec;94(12):1601-6. doi: 10.1136/hrt.2007.125708. Epub 2008 May 1.


Cost effectiveness of nurse led secondary prevention clinics for coronary heart disease in primary care: follow up of a randomised controlled trial.

Raftery JP, Yao GL, Murchie P, Campbell NC, Ritchie LD.

BMJ. 2005 Mar 26;330(7493):707. Epub 2005 Feb 16.


Costs and cost effectiveness of cardiovascular screening and intervention: the British family heart study.

Wonderling D, McDermott C, Buxton M, Kinmonth AL, Pyke S, Thompson S, Wood D.

BMJ. 1996 May 18;312(7041):1269-73. Erratum in: BMJ 1996 Jul 27;313(7051):198.


An economic analysis of specialist heart failure nurse management in the UK; can we afford not to implement it?

Stewart S, Blue L, Walker A, Morrison C, McMurray JJ.

Eur Heart J. 2002 Sep;23(17):1369-78.


Cost effectiveness of the Expert Patients Programme (EPP) for patients with chronic conditions.

Richardson G, Kennedy A, Reeves D, Bower P, Lee V, Middleton E, Gardner C, Gately C, Rogers A.

J Epidemiol Community Health. 2008 Apr;62(4):361-7. doi: 10.1136/jech.2006.057430.


Costs of a community pharmacist-led medicines management service for patients with coronary heart disease in England: healthcare system and patient perspectives.

Scott A, Tinelli M, Bond C; Community Pharmacy Medicines Management Evaluation Team.

Pharmacoeconomics. 2007;25(5):397-411.


Occupational therapy compared with social work assessment for older people. An economic evaluation alongside the CAMELOT randomised controlled trial.

Flood C, Mugford M, Stewart S, Harvey I, Poland F, Lloyd-Smith W.

Age Ageing. 2005 Jan;34(1):47-52. Epub 2004 Nov 10.


The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation.

Hind D, Tappenden P, Tumur I, Eggington S, Sutcliffe P, Ryan A.

Health Technol Assess. 2008 May;12(15):iii-ix, xi-162. Review.


Cost-utility analysis of osteopathy in primary care: results from a pragmatic randomized controlled trial.

Williams NH, Edwards RT, Linck P, Muntz R, Hibbs R, Wilkinson C, Russell I, Russell D, Hounsome B.

Fam Pract. 2004 Dec;21(6):643-50. Epub 2004 Nov 5.


Shoulder acute pain in primary health care: is retraining GPs effective? The SAPPHIRE randomized trial: a cost-effectiveness analysis.

McKenna C, Bojke L, Manca A, Adebajo A, Dickson J, Helliwell P, Morton V, Russell I, Torgerson D, Watson J.

Rheumatology (Oxford). 2009 May;48(5):558-63. doi: 10.1093/rheumatology/kep008. Epub 2009 Mar 3.


Evaluation of a self-management programme for congestive heart failure patients: design of a randomised controlled trial.

Smeulders ES, van Haastregt JC, van Hoef EF, van Eijk JT, Kempen GI.

BMC Health Serv Res. 2006 Jul 20;6:91.


Cost-utility of a walking programme for moderately depressed, obese, or overweight elderly women in primary care: a randomised controlled trial.

Gusi N, Reyes MC, Gonzalez-Guerrero JL, Herrera E, Garcia JM.

BMC Public Health. 2008 Jul 8;8:231. doi: 10.1186/1471-2458-8-231.


Economic evaluation of arthritis self management in primary care.

Patel A, Buszewicz M, Beecham J, Griffin M, Rait G, Nazareth I, Atkinson A, Barlow J, Haines A.

BMJ. 2009 Sep 22;339:b3532. doi: 10.1136/bmj.b3532.


Two-year outcome of a prospective, controlled study of a disease management programme for elderly patients with heart failure.

Del Sindaco D, Pulignano G, Minardi G, Apostoli A, Guerrieri L, Rotoloni M, Petri G, Fabrizi L, Caroselli A, Venusti R, Chiantera A, Giulivi A, Giovannini E, Leggio F.

J Cardiovasc Med (Hagerstown). 2007 May;8(5):324-9.


Secondary prevention in coronary heart disease: a randomised trial of nurse led clinics in primary care.

Campbell NC, Ritchie LD, Thain J, Deans HG, Rawles JM, Squair JL.

Heart. 1998 Nov;80(5):447-52.


Cost-effectiveness of involving nurse specialists for adult patients with urinary incontinence in primary care compared to care-as-usual: an economic evaluation alongside a pragmatic randomized controlled trial.

Albers-Heitner CP, Joore MA, Winkens RA, Lagro-Janssen AL, Severens JL, Berghmans LC.

Neurourol Urodyn. 2012 Apr;31(4):526-34. doi: 10.1002/nau.21204. Epub 2012 Jan 24.


Long-term cost-effectiveness of disease management in systolic heart failure.

Miller G, Randolph S, Forkner E, Smith B, Galbreath AD.

Med Decis Making. 2009 May-Jun;29(3):325-33. doi: 10.1177/0272989X08327494. Epub 2009 Jan 15.


Economic analysis of treatments reducing coronary heart disease mortality in England and Wales, 2000-2010.

Fidan D, Unal B, Critchley J, Capewell S.

QJM. 2007 May;100(5):277-89. Epub 2007 Apr 21.

Items per page

Supplemental Content

Write to the Help Desk